All filters
Slidesets
Core Inhibitors (Capsid Assembly Modulators) - Luisa Stamm, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Biological Insights Taught by Clinical Responses to Novel Hbv-Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation - P. Mishra, MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
How to Handle Flares in HBV Trials With Novel Agents - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
A Novel Approach At Targeting the PD-1PD-l1 Pathway - PD-l1 Lna - A
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci
Presented at:
International Workshop on HBV Cure 2021
Slidesets
VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Immunotherapeutics in the Treatment of Chronic Hepatatis B - S. Browne, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Anti-HBs Antibody - C. Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Data From Combination Trials for Chronic Hepatitis B - P. Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
COVID-19 Challenges and Scale-up in Access to Community-Based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine - Zahedul Islam
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Dynamics and Peculiarities of AIDS Mortality in Minsk, Belarus - Shylava, Marharyta
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
SARS-CoV-2 Antibody Seroprevalence in Previously Undiagnosed Persons in Tbilisi, Georgia: Results of Three Repeated Serosurveys - Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV & COVID-19 Coinfection - Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD
Dr. Kuritzkes, Daniel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhD
Dr. Molina, Jean-Michel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Long-Acting Therapy for PrEP: How Will We Use it? - Luis Mendão
Mr. Mendão, Luis
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MSc
Dr. Noori, Teymur
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Update on the Use of Generic Drugs for HIV in Europe - Liudmyla Maistat
Ms. Maistat, Liudmyla
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021